🇺🇸 FDA
Patent

US 10208111

Alpha-synuclein antibodies and uses thereof

granted A61PA61P25/00A61P25/16

Quick answer

US patent 10208111 (Alpha-synuclein antibodies and uses thereof) held by UNITED ARAB EMIRATES UNIVERSITY expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
UNITED ARAB EMIRATES UNIVERSITY
Grant date
Tue Feb 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P25/00, A61P25/16, A61P25/18, A61P25/28